Stephen Giangrande

Clinical Specialist for Penumbra inc. Northeast Region

[Penumbra Vascular @PenVascular]

US HCPs: @rAlexPowellMD discusses STRIDE and its data comparing outcomes in in-stent vs native vessel disease.

🔗 View the STRIDE study: https://t.co/GPSYhTiw39

Rx only. Risk: https://t.co/SILdiRZoH4 Clinical results may vary

[Venkat Tummala MD MBA @t_intheleadcoat]

Yesterday was a monumental day for PE pts & for the space with the FIRST ever RCT reporting outcomes comparing mechanical thrombectomy #CAVT to standard AC in intermediate high risk PE. Results show superiority to AC at effectively & rapidly reversing RV/ LV ratio with a comparable safety profile !

Congratulations & Thank you to #STORM-PE Steering committee & Investigators for their contributions to this landmark trial!

@TCTMD @SIRspecialists @PERTConsortium @PenVascular

[Stephen Giangrande @StephenGiangran]

@ChengaziMD @parkhurst42 @NoLimitIR @SDhandMD @karananandpara @keithppereira @_backtable @t_intheleadcoat @Pandarock5 @DonGarbettMD @iRadRock @IRKhalsa @TheRealDoctorOs I love all of this, you guys are all legends in my eyes!!

[Penumbra Vascular @PenVascular]

US HCPs: Providing more coil and more volume, #RubyXL is designed to offer unmatched efficiency – all through your preferred diagnostic catheter. #NewClassOfCoil #SomethingBIGIsHERE

Rx only. Risk: https://t.co/SILdiRZoH4 Clinical results may vary

[Penumbra Vascular @PenVascular]

US HCPs: #RubyXL is the latest addition to the #RubyEmbolizationPlatform, designed to simplify embolization procedures in large, high-flow vasculature. #NewClassOfCoil #SomethingBIGIsHERE

Rx only. Risk: https://t.co/SILdiRZoH4 Clinical results may vary

[Harris Chengazi @ChengaziMD]

#mesocaval shunt was popular, another 4DCT case

Invasive Pancreatic ca, recurrent duodenal GIB. Pt couldn’t be discharged for chemo. Mesocaval shunt allowed for safe discharge and chemotherapy (tolerating well). Blunt Hawkins allowed navigation around stomach/mesentery. #chogazi

[Penumbra, Inc. @penumbrainc]

Read more about the seven new data sets presented at #SIR25NASH here: https://t.co/bi9MZiY0eC

#CAVT #MedTech #MedDevice #Innovation @SIRspecialists

[Penumbra Vascular @PenVascular]

US HCPs: With the announcement of EMBOLIZE, Penumbra continues to move the field of embolization forward. This case from Dr. Thomas Khoury shows the value of #MechanicalOcclusion for pelvic venous disorders.

Rx only. Risk info: https://t.co/SILdiRZoH4 Clinical results may vary

[Penumbra Vascular @PenVascular]

US HCPs: Occluded Renal Artery cleared with #CAVT, read more here: https://t.co/WFwblv5wgp

[Penumbra Vascular @PenVascular]

US HCPs: Tune in to see Penumbra's coil platform in action. With low recanalization rates, see how #MechanicalOcclusion outperforms thrombus-dependent occlusion. (1, 2) #PackWithPenumbra

Rx only. Risk: https://t.co/SILdiRZoH4 Clinical results may vary.

[Penumbra Vascular @PenVascular]

US HCPs: See us at #VIVAVEINS24 to discuss a retrospective, propensity-matched study of the Vizient Clinical Data Base on how therapies for intermediate-risk PE improve outcomes & optimize healthcare resources #CAVT Rx only. Risk: https://t.co/SILdiRZoH4 Clinical results may vary

[Penumbra Vascular @PenVascular]

Check out our latest #STRIDE subset results showing procedural success with thrombolytic free, single session aspiration mechanical thrombectomy. #CAVT

[Endovascular Today @EVToday]

US HCPs: NOW is the TIME for Lightning Flash 2.0. The next generation of Penumbra's Computer Assisted Vacuum Thrombectomy platform. #CAVT #NOWISTHETIME

Rx only. Risk info: https://t.co/5m8iyKrIuN Clinical results may vary. | #Sponsored by @penumbrainc @PenVascular

[Penumbra, Inc. @penumbrainc]

Our CEO, Adam Elsesser, was featured in Newsweek’s “The New Era of Lifesciences” report this week, highlighting how our latest #CAVT will transform clot care. Read more here: https://t.co/79he3pwGkn

[Lauren Jaeger, MBA, MPH (She/Her) @LaurenJaeger13]

#FLASHjustgotFASTER #continuousinnovation #thrombectomy #dvt #pe

[Shruthi Narayan @knshruthi]

Thought-provoking insight from the STRIDE study demonstrating similar high limb salvage rates in male and female patients with LE-ALI. Thank you to the STRIDE investigators for helping gather this important data. #CAVT

[Shruthi Narayan @knshruthi]

Looking forward to another energizing SIR! See you there!

[Harris Chengazi @ChengaziMD]

Restoring physiologic flow is such a treat.

Pt with incidental IVC occlusion/thrombus on liver Doppler to work up ascites. #VIRad #WithoutAScalpel #venous #thrombectomy #MedTwitter #MedEd #GItwitter @SIR_ECS @_backtable @CHICKVIR @VascularSVS @t_intheleadcoat

[Penumbra Vascular @PenVascular]

US HCPs: ⚡ Check out this #LightningFlash PE case by @drochohan with under 100cc EBL! 🫁 #FeelThePower with #CAVT

Rx only. Risk info: https://t.co/SILdiRZWwC Clinical results may vary

[Penumbra Vascular @PenVascular]

Want to learn how to remove clot in a New York minute? Join us at #VEITHsymposium to hear how the experts are incorporating Computer Assisted Vacuum Thrombectomy (CAVT) into their treatment algorithm. See you in NYC!